Drug class
Fluoroquinolone antibacterial; bacterial DNA gyrase and topoisomerase IV inhibitor
Mechanism of action
Inhibits bacterial type II topoisomerases, DNA gyrase and topoisomerase IV, trapping enzyme-DNA cleavage complexes and preventing DNA replication and transcription. This produces bactericidal activity against susceptible Gram-negative and Gram-positive organisms.
General use cases
- Historically used for susceptible systemic bacterial infections, including selected urinary, gastrointestinal and respiratory infections, where authorised.
- Use is restricted or withdrawn in some jurisdictions because of potentially disabling and long-lasting fluoroquinolone adverse effects; follow current local authorisation and product information.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
